Lipoprotein subclasses are associated with Hepatic steatosis: insights from the prospective multicenter imaging study for the evaluation of chest pain (PROMISE) clinical trial-Reference-Cited by-同舟云学术

Lipoprotein subclasses are associated with Hepatic steatosis: insights from the prospective multicenter imaging study for the evaluation of chest pain (PROMISE) clinical trial

Published:2024-06 Issue: Volume:18 Page:100680
ISSN:2666-6677
Container-title:American Journal of Preventive Cardiology
language:en
Short-container-title:American Journal of Preventive Cardiology

Author:

Karady Julia^ORCID,McGarrah Robert W,Nguyen Maggie,Giamberardino Stephanie N,Meyersohn Nandini,Lu Michael T,Staziaki Pedro V,Puchner Stefan B,Bittner Daniel O,Foldyna Borek,Mayrhofer Thomas,Connelly Margery A,Tchernof Andre,White Phillip J,Nasir Khurram,Corey Kathleen,Voora Deepak,Pagidipati Neha,Ginsburg Geoffrey S,Kraus William E,Hoffmann Udo,Douglas Pamela S,Shah Svati H,Ferencik Maros

Publisher

Elsevier BV

Reference40 articles.

1. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study;Williams;Gastroenterology,2011

2. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity;Browning;Hepatology,2004

3. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort;Harrison;J Hepatol,2021

4. Association of Hepatic Steatosis with Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease;Meyersohn;Clin Gastroenterol Hepatol,2020

5. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA);Al Rifai;Atherosclerosis,2015